MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclosure

05 Jan 2023 Evaluate

Oxygenta Pharmaceutical has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Popuri Sudharani & Popuri Ankineedu.


The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..